CCL2 and metabolic syndrome: Our data suggest a possible positive role for IL-6 in suppressing the level of TNF-α and MCP-1, in maintaining adipose tissue homeostasis and in preventing the consequences of high proinflammatory cytokine levels, as insulin resistance and other elements of the metabolic syndrome.